NEW YORK (Diya TV) — Federal prosecutors are reviewing possible financial irregularities at two insurance companies linked to billionaire Mark Walter. The inquiry centers on whether the companies properly disclosed billions of dollars in private credit investments tied to other businesses within Walter’s financial network. At the same time, investigators continue a separate review involving Guggenheim Partners, according to company filings and a Bloomberg report.
The investigation focuses on Delaware Life Insurance and Clear Spring Life and Annuity, both owned by Group 1001. Federal prosecutors in Manhattan issued grand jury subpoenas to the companies in February. The subpoenas asked questions about the insurers’ reporting of private credit investments and whether those assets had stronger connections to Walter-controlled businesses than the companies disclosed.
Meanwhile, the U.S. Securities and Exchange Commission is conducting a separate civil review of the same issues. Both investigations continue, and officials have not announced any charges against the companies or any individuals.
Group 1001 said it is cooperating fully with federal authorities. The company also said its financial position remains strong despite the ongoing investigations.
According to regulatory filings dated June 26, prosecutors questioned whether the insurers properly identified certain investments as related-party transactions. Those investments involved billions of dollars in private credit holdings connected to other businesses within Walter’s wider business empire.
After receiving the subpoenas, Delaware Life and Clear Spring launched internal reviews. As a result, the companies found reporting errors and updated earlier disclosures. Those reviews revealed broader financial connections between the insurers and affiliated Walter-controlled entities than previously reported.
Delaware Life disclosed an additional $16 billion in private credit assets linked to affiliated businesses. The updated filing showed that the company’s financial ties extended further than earlier reports had indicated. However, the filing did not state that the assets were improperly managed or that investors suffered financial losses.
The companies also did not specify when they first made the private credit investments now under review. However, the filings indicate that the investments date back more than two years.
The federal inquiry into the insurers follows an earlier investigation involving Guggenheim Partners, Walter’s investment management business. Prosecutors began that review last year. Bloomberg reported that investigators examined statements Guggenheim made to outside parties regarding its revenue figures. However, officials have not disclosed the current status of that investigation.
In a separate development, the FBI executed at least one search warrant in September and seized a mobile device. Authorities have not explained whether that action relates to the insurance investigation, the Guggenheim review, or another matter. As a result, the connection remains unclear.
Walter oversees a wide range of business interests through several investment firms. His portfolio includes ownership stakes in the Los Angeles Dodgers, the Los Angeles Lakers, and Chelsea Football Club. Those high-profile investments have placed his business activities under increased public attention as the investigations continue.
Even so, the filings emphasize that Delaware Life and Clear Spring remain financially stable. As of March, Delaware Life reported approximately $69 billion in assets. Clear Spring reported about $16 billion in assets during the same period.
The central issue for investigators involves financial disclosure rather than the performance of the investments themselves. Prosecutors want to determine whether the insurers accurately informed regulators about relationships between their private credit holdings and other Walter-linked businesses. Regulators often require companies to disclose related-party transactions because investors and policyholders rely on transparent financial reporting.
